Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gem AromaticsNSE:GEMAROMA -0.44%19 EBITDA Margin % is 3.51% as of Jun. 2026, which is 79% below its 10-year median of 16.50. GuruFocus rates NSE:GEMAROMA with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 1,583 Chemicals companies, Gem Aromatics ranks worse than 61.97% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gem Aromatics's EBITDA for the
three
months ended in Jun. 2026 was ₹35 Mil. Gem Aromatics's Revenue for the
three
months ended in Jun. 2026 was ₹989 Mil. Therefore, Gem Aromatics's EBITDA margin for the quarter that ended in Jun. 2026 was 3.51%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Gem Aromatics EBITDA Margin % Related Terms
Gem Aromatics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Gem Aromatics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Gem Aromatics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gem Aromatics EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Gem Aromatics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Gem Aromatics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gem Aromatics (NSE:GEMAROMA) has a EBITDA Margin % of 3.51% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gem Aromatics and its competitors. This is 79% below median its historical median of 16.50. Over the past decade, Gem Aromatics' EBITDA Margin % has ranged from 7.64 to 18.10. According to the industry distribution chart, Gem Aromatics ranks #981 out of 1583 companies in the Chemicals industry, placing it in the top 62%.
Is Gem Aromatics' EBITDA Margin % too high?
Gem Aromatics' current EBITDA Margin % of 3.51% is 79% below median its 10-year median of 16.50. Over the past 10 years, this metric has ranged from a low of 7.64 to a high of 18.10. The Chemicals industry median EBITDA Margin % is 10.62. Gem Aromatics' value of 3.51% is 66.9% below this industry median. Based on the distribution chart, Gem Aromatics ranks #981 out of 1583 companies in the Chemicals industry, which is below the industry midpoint. Overall, Gem Aromatics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Gem Aromatics' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Gem Aromatics ranks #981 out of 1583 companies for EBITDA Margin %. This places Gem Aromatics in the lower half of its industry. The industry median EBITDA Margin % is 10.62. Gem Aromatics' value of 3.51% is 66.9% below this benchmark. Historically, Gem Aromatics' own EBITDA Margin % has ranged from 7.64 to 18.10 over the past decade. While the company's 10-year median is 16.50 vs. the industry median of 10.62, Gem Aromatics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 10.62, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gem Aromatics's current EBITDA Margin % of 3.51% is 66.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gem Aromatics and its competitors. For the Chemicals industry, the median EBITDA Margin % is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gem Aromatics's current EBITDA Margin % is 3.51%, which is 79% below median its own 10-year median of 16.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gem Aromatics stock overvalued right now?
Gem Aromatics (NSE:GEMAROMA) has a current EBITDA Margin % of 3.51%. The current EBITDA Margin % is 3.51%, which is 79% below median its 10-year median of 16.50 and 66.9% below the Chemicals industry median of 10.62. Gem Aromatics' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gem Aromatics (NSE:GEMAROMA), the current EBITDA Margin % is 3.51% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gem Aromatics Ltd is an established manufacturer of specialty ingredients, including, essential oils, aroma chemicals and Value Added Derivatives in India. It offers a diversified portfolio of products, ranging from the Mother Ingredients to its various Value-Added Derivatives. Its products find application across a broad spectrum of industries, such as, oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management and personal care. The company offers approximately 70 products across its four product categories, namely, (i) mint and mint derivatives; (ii) clove and clove derivatives; (iii) phenol; and (iv) other synthetic and natural ingredients.
19GF Score
Get the complete analysis for NSE:GEMAROMA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GEMAROMA has been successfully added to your 
